A Therapeutic System of 177Lu-labeled Gold Nanoparticles-RGD Internalized in Breast Cancer Cells
DOI:
https://doi.org/10.29356/jmcs.v57i3.209Keywords:
gold nanoparticles, radiolabeled nanoparticles, radio-gold nanoparticles, radiolabeled peptides, nanoparticle-peptide, RGD peptide, lutetium-177Abstract
The aim of this research was to evaluate the in vitro potential of 177Lu-labeled gold nanoparticles conjugated to cyclo-[RGDfK(C)] peptides (177Lu-AuNP-c[RGDfK(C)]) as a plasmonic photothermal therapy and targeted radiotherapy system in MCF7 breast cancer cells. Peptides were conjugated to AuNPs (20 nm) by spontaneous reaction with the thiol group of cysteine (C). After laser irradiation, the presence of c[RGDfK(C)]-AuNP in cells caused a significant increase in the temperature of the medium (50.5 °C, compared to 40.3 °C without AuNPs) resulting in a significant decrease in MCF7 cell viability down to 9 %. After treatment with 177-AuNP-c[RGDfK(C)], the MCF7 cell proliferation was significantly inhibited.Downloads
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.